Author/Authors :
Chaucer, Benjamin University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Stone, Abriella University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Demanes, Augustus University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Seibert, Shawn M. llinois Cancer Care - Peoria - IL, USA
Abstract :
e treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects ofthese agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonlyused for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common sideeffects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of anextremely rare side effect to a common chemotherapeutic agent
